Cocrystal Pharma, Inc. (NASDAQ:COCP)

About the company

Cocrystal Pharma, Inc. is a biotechnology company, which engages in the discovery and development of novel antiviral therapeutics. It focuses on the preclinical and early clinical stage antiviral compounds for unmet medical needs including influenza, Hepatitis C virus, and norovirus infections. The company was founded on January 2, 2014 and is headquartered in Bothell, WA.

Sector

Health Technology

Industry

Pharmaceuticals: Generic

Employees

11

$2.00M

Total Revenue

11

Employees

$53.55M

Market Capitalization

-0.92

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

$1M

Operating Margin (in %)

Total operating margin

$-7M

Net Margin (in %)

Total net margin

$-15M

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
Zoetis, Inc. ZTS 66589.64 6339.00 23.87 41.45 25.41
Mylan NV MYL 8551.18 11624.00 0.76 137.83 0.54
BridgeBio Pharma, Inc. BBIO 3590.07 41.00 9.45 -12.36 -718.08
Taro Pharmaceutical Industries Ltd. TARO 2591.60 645.00 1.24 10.74 37.88
TherapeuticsMD, Inc. TXMD 388.62 58.00 -9.00 -1.99 -333.88
Abeona Therapeutics, Inc. ABEO 210.80 3.00 2.15 -2.07 75.95
LifeVantage Corp. LFVN 189.90 230.00 6.36 16.03 5.06
Kindred Biosciences, Inc. KIN 150.93 4.00 2.51 -2.21 None
Cocrystal Pharma, Inc. COCP 53.55 2.00 1.96 -0.92 -733.84
China Pharma Holdings, Inc. CPHI 26.40 10.00 3.16 -1.22 -214.63
Jaguar Health, Inc. JAGX 4.86 5.00 3.60 0.07 -887.14

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

BRIEF-Cocrystal Pharma Says Board Approves Increase In Annual Base Salary Of CEO

3d ago, source: Reuters

COCRYSTAL PHARMA INC - ON JUNE 22, BOARD APPROVED INCREASE IN ANNUAL BASE SALARY OF CEO FROM $200,000 TO $315,000 * COCRYSTAL PHARMA INC - BOARD APPROVED INCREASE IN ANNUAL BASE SALARY OF PRESIDENT ...

Cocrystal Pharma Inc.

6d ago, source: Barron's

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

BRIEF-Cocrystal Pharma Says Co May Offer, Sell Shares Of Common Stock

7d ago, source: Reuters

July 1 (Reuters) - Cocrystal Pharma Inc: * COCRYSTAL PHARMA INC - MAY OFFER, SELL SHARES OF COMMON STOCK HAVING AGGREGATE OFFERING PRICE OF UP TO $10 MILLION FROM TIME TO TIME Source text (bit.ly ...

COCP Cocrystal Pharma, Inc. Common Stock

14d ago, source: Nasdaq

Insider Trading information for NDAQ is derived from Forms 3 and 4 filings filed with the U.S. Securities and Exchange Commission (SEC). Please Note:An FPI is exempt of filing insider holdings ...

Talks Underway To End Cocrystal Pharma Stock-Drop Suit

29d ago, source: Law360

Law360 (June 8, 2020, 3:26 PM EDT) -- Settlement talks are underway in a derivative suit brought by Cocrystal Pharma Inc. shareholders over a $27 million pump-and-dump scheme that purportedly ...

BRIEF-Cocrystal Pharma Says Board Approves Increase In Annual Base Salary Of CEO

11d ago, source: Reuters

June 26 (Reuters) - Cocrystal Pharma Inc: * COCRYSTAL PHARMA INC - ON JUNE 22, BOARD APPROVED INCREASE IN ANNUAL BASE SALARY OF CEO FROM $200,000 TO $315,000 * COCRYSTAL PHARMA INC - BOARD ...



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.